Relationship between levels of secreted phospholipase A2 groups IIA and X in the airways and asthma severity

Clinical and Experimental Allergy

Volumn 41, Issue 6, 2011, Pages 801-810

  Hallstrand, T S ^a   Lai, Y ^a   Ni, Z ^b   Oslund, R C ^b   Henderson, W R ^b   Gelb, M H ^b   Wenzel, S E ^c  

^a Divisions of Pulmonary and Critical Care ^*  (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Eicosanoid; Epithelial cell; Leukotriene; Phospholipase

Indexed keywords

ICOSANOID; LEUKOTRIENE; PHOSPHOLIPASE A2 GROUP II; PHOSPHOLIPASE A2 GROUP V; PHOSPHOLIPASE A2 GROUP X; PROSTAGLANDIN E2;

ADULT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; HUMAN; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM;

ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROUP II PHOSPHOLIPASES A2; GROUP X PHOSPHOLIPASES A2; HUMANS; MALE; MIDDLE AGED; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS;

EID: 79955757953     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03676.x     Document Type: Article

References (31)

1. Hallstrand TS, Henderson WR Jr An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 2010; 10:60-6.
2. 2 in inflammatory and allergic diseases: not just enzymes. J Allergy Clin Immunol 2005; 116:1000-6.
3. 1 macrophage-like cells. J Biol Chem 2003; 278:48059-65.
4. 2-α. J Biol Chem 2004; 279:25024-38.
5. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J Biol Chem 2004; 279:16488-94.
6. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997; 155:421-5.
7. Chilton FH, Averill FJ, Hubbard WC, Fonteh AN, Triggiani M, Liu MC. Antigen-induced generation of lyso-phospholipids in human airways. J Exp Med 1996; 183:2235-45.
8. 2 from human nasal lavage. Am J Respir Cell Mol Biol 1994; 11:108-13.
9. 2. J Allergy Clin Immunol 2009; 124:558-65, 65 e1-3.
10. Hallstrand TS, Chi EY, Singer AG, Gelb MH, Henderson WR Jr Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2007; 176:1072-8.
11. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 2007; 204:865-77.
12. 2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J Immunol 2007; 179:4800-7.
13. Moore WC, Bleecker ER, Curran-Everett D et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:405-13.
14. Pavord ID, Ward R, Woltmann G, Wardlaw AJ, Sheller JR, Dworski R. Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med 1999; 160:1905-9.
15. Romagnoli M, Vachier I, Tarodo de la Fuente P et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002; 20:1370-7.
16. Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156:737-43.
17. 2 in human serum. Biochim Biophys Acta 2005; 1733:210-23.
18. 2-X) and asthma severity (abstract). Proc Am Thorac Soc 2009; 179:A5441.
19. American Thoracic Society Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000; 162:2341-51.
20. National Institutes of Health NH Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health, 2007.
21. 2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol 2006; 117:1446-54.
22. Fahy JV, Boushey HA, Lazarus SC et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med 2001; 163:1470-5.
23. 2s in human neutrophils: role in eicosanoid production and gram-negative bacterial phospholipid hydrolysis. J Biol Chem 2002; 277:5061-73.
24. 2. J Biol Chem 2002; 277:48535-49.
25. 2 4-glycerol derivatives of 4, 5-dihydro-3-(4-tetradecyloxybenzyl)-1, 2, 4-4H-oxadiazol-5-one with broad activities. J Med Chem 2007; 50:1618-26.
26. Carraro S, Corradi M, Zanconato S et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005; 115:764-70.
27. Hallstrand TS, Moody MW, Aitken ML, Henderson WR Jr Airway immunopathology of asthma with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005; 116:586-93.
28. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR Jr, Aitken ML. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005; 172:679-86.
29. Mickleborough TD, Lindley MR, Ray S. Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma. Med Sci Sports Exerc 2005; 37:904-14.
30. 2 activity in patients with asthma: association with body mass index and cholesterol concentration. Thorax 2008; 63:21-6.
31. 2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma 2005; 42:65-71.